Loading
No description yet: the sentence for this tag has not been written. 5 records carry it: 3 people, 1 trial, 1 technology.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Caroline Moore Professor of Urology and Head of Urology, Department of Targeted Intervention, University College London; Honorary Consultant Urologist, University College London Hospitals · University College London Hospitals / UCL Cancer Institute The UCL urologist who has spent her career on the two questions that decide whether a man with prostate cancer is harmed by being diagnosed: who needs a biopsy, and who needs treating at all. | Prostate cancer, Localised prostate cancer, very low and low risk, Localised prostate cancer, intermediate risk | none | prostate, uk | ||
Immunoglobulin and T-cell receptor clonality testing A test that asks whether a group of lymphocytes is one family descended from a single cell, or a crowd of unrelated ones. Cancer is one family. It is used when the appearance under the microscope is not enough to decide. | Non-Hodgkin lymphoma, Cutaneous T-cell lymphoma, Sezary syndrome | lymphoma | |||
Michael F. Berger Associate Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center · Memorial Sloan Kettering Cancer Center Built MSK-IMPACT, the tumour sequencing test used on more than 100,000 patients and the first FDA-authorised hospital panel. | none | none | genomics, precision-oncology | ||
PROMIS ISRCTN16082556 The British study that measured how bad the standard prostate biopsy really was, and how good a scan could be instead: the evidence that put MRI before the needle in the NHS. | Prostate cancer, Localised prostate cancer, very low and low risk, Localised prostate cancer, intermediate risk | uk, prostate | |||
Viktor A. Adalsteinsson Director, Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard · Broad Institute of MIT and Harvard Engineer who showed low-pass sequencing of blood can replace tumour biopsies and built ultra-sensitive MRD tests. | none | none | ctdna, mrd |